Trxade Group (NASDAQ: MEDS), an integrated drug
procurement, delivery and healthcare platform that enables drug availability,
care services and price transparency for both pharmacists and consumers, today
announced that it will exhibit at HIMSS 2020. The event, which will draw over
45,000 healthcare professionals, is slated to take place at the Orange County
Convention center in Orlando, Florida from March 9-13. Trxade’s booth will be
located in Exhibit Hall E, Booth (#7273), Kiosk (#13). Members from the
company’s leadership team will be present and provide detailed DEMO and
information on products including: DelivMeds and Bonum Health, demonstrating
the latest advances in value-based remote patient care and pharmaceutical
services, to bridge gaps where care is limited, enhance patient knowledge and
improve healthcare management.
To view the full press release, visit http://ibn.fm/hjJuF
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ:
MEDS) is an integrated drug procurement, delivery and healthcare platform that
enables price transparency and increased profit margins to healthcare buyers
and sellers of pharmaceuticals, accessories and services. Founded in 2010,
Trxade Group is comprised of three synergistic operating platforms; the Trxade
B2B trading platform with 11,900 registered pharmacies, licensed virtual
Wholesale and Mail Order Pharmacy capabilities including DelivMeds, as well as
the newly acquired assets of Bonum Health. For additional information, please
visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
